Gene Bridges GmbH

Im Neuenheimer Feld 584
69120 Heidelberg
Germany

Contact

About Gene Bridges

Gene Bridges GmbH is a self-financed biotech company pioneering recombineering, the fast and precise method of engineering gene sequences. The Company was founded in 2000 as spin-off from the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany. Gene Bridges commercialises its patented recombineering technology through services, commercial licenses and kits from its facilities in Heidelberg as well as through its distributors worldwide.

Product portfolio of Gene Bridges

Product portfolio

Show all

News about Gene Bridges

02-Jun-2009 | business & finance

Gene Bridges Licenses Recombineering Technology to Chugai Pharmaceutical Co., Ltd.

Gene Bridges GmbH announced that Chugai Pharmaceutical Co., Ltd. of Tokyo, Japan has completed the amendment to expand the commercial license agreement ...

Read news

27-Mar-2009 | business & finance

Gene Bridges Licenses Recombineering Technology to Daiichi Sankyo Co., Ltd.

Gene Bridges GmbH announced that Daiichi Sankyo Co., Ltd. has completed a commercial license agreement for the use of the Red/ET recombination technology ...

Read news

01-Aug-2008 | research and development

Gene Bridges granted Patents in Japan and Mexico for Recombineering Technology

Gene Bridges GmbH announced that it has been granted patents in Japan and in Mexico relating to the Company's recombineering technology. The Japanese ...

Read news

23-Apr-2008 | business & finance

Gene Bridges licenses Red/ET Recombineering to Novozymes

Gene Bridges GmbH announced that Novozymes has completed a commercial license agreement for the use of the Red/ET recombination technology from Gene ...

Read news

02-Apr-2008 | business & finance

Gene Bridges licenses Red/ET Recombineering to Genencor

Gene Bridges GmbH announced that Genencor International Inc. USA, a part of Danisco US Inc., has completed a commercial license agreement for the use of ...

Read news

22-Feb-2008 | business & finance

Mbiotech to distribute Gene Bridges Recombineering Technology in Korea

Gene Bridges GmbH announced that Mbiotech will distribute Gene Bridges' patented Red/ET recombination technology in Korea. Mbiotech was selected due to its ...

Read news

10-Jan-2008 | research and development

Gene Bridges granted Korean Patent for Recombineering Technology

Gene Bridges GmbH announced that it has been granted Korean Patent No. 10-0751587, entitled "Methods and compositions for directed cloning and sub-cloning ...

Read news

17-Feb-2004 | business & finance

Gene Bridges Announces Distribution Agreement with CAMBIO for Red/ET Recombination Kits

DRESDEN, Germany - Gene Bridges GmbH announced today, that CAMBIO Ltd., Cambridge, UK, has agreed to distribute Gene Bridges' Red/ET Recombination Kits in ...

Read news

Show more news about Gene Bridges

Gene Bridges GmbH

About Gene Bridges

Product portfolio of Gene Bridges

Product portfolio

Merck Life Science KGaA

CANDOR Bioscience GmbH

Cytiva Europe GmbH

Jena Bioscience GmbH

News about Gene Bridges

Gene Bridges Licenses Recombineering Technology to Chugai Pharmaceutical Co., Ltd.

Gene Bridges Licenses Recombineering Technology to Daiichi Sankyo Co., Ltd.

Gene Bridges granted Patents in Japan and Mexico for Recombineering Technology

Gene Bridges licenses Red/ET Recombineering to Novozymes

Gene Bridges licenses Red/ET Recombineering to Genencor

Mbiotech to distribute Gene Bridges Recombineering Technology in Korea

Gene Bridges granted Korean Patent for Recombineering Technology

Gene Bridges Announces Distribution Agreement with CAMBIO for Red/ET Recombination Kits

Here you will find Gene Bridges GmbH